News
  • No news at this moment
  March  
MonTueWedThuFriSatSun
12345
6789101112
13141516171819
20212223242526
2728293031

The projects constituting the SEURAT-1 research initiative have received funding from the European Union Seventh Framework Programme (FP7/2007-2013). The projects constituting the SEURAT-1 research initiative have received financing from Cosmetics Europe.

News

HemoGenix: In VitroPredictive Toxicity Testing

04/03/2012
News >>

 

topbanner

In VitroPredictive Toxicity Testing


In vitro toxicity testing can range from using cell lines to detecting primitive stem cell populations in tissues explanted during animal studies. But, the most predictive in vitro toxicity testing is when primary human tissues are used for screening during the earliest stages of drug development. HemoGenix® has developed assays just for that purpose.
 

  • Stem cell predictive toxicity assays
  • Validated assays for specific tissues and applications
  • Compare potential toxicity in different cell systems, tissues, and species with human primary cells
  • Mechanism of action
  • Cellular drug-drug interaction
  • All stages of drug development, from high throughput screening to patient monitoring
  • GLP or non-GLP

www.hemogenix.com

Testing
Services

 


Hemotoxicity Testing
Immunotoxicity Testing
MSC Toxicity Testing
Hepatotoxicity Testing
Neurotoxicity Testing
Cell System Toxicity Testing
Stem Cell Toxicity Testing
Drug-Drug Interaction
Predictive Residual Toxicity
Comparative Toxicity
Oxidative DNA Damage

 


White Paper:

"Stem Cells and Predictive In Vitro Toxicity Testing"

Download

 

Last changed: 04/03/2012

Back